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 “Our arsenals for fighting the bacteria are so powerful that we are 
in more danger from them than from the invader” 
--   Lewis Thomas 
                             INTRODUCTION 
Surgical site infections are one of the most common hospital 
acquired infections, which constitute 38% of surgical infections. It 
creates great burden to the patients by increasing hospital stay by 7-10 
days. Also, it increases hospital expenditures creating an economic 
burden to the patient and country. 
 
Basis of antimicrobial prophylaxis 
              The basis of prophylaxis is to obtain appropriate levels of the 
drugs in serum and tissues that exceed the Minimum Inhibitory 
Concentrations (MIC) for the likely micro organisms causing a specific 
surgical infection. 
   It is considered optimal if the antibiotic is administered 30 
minutes before putting a skin incision or at the time of induction of 
anaesthesia. Usually single dosage of antimicrobial agent is optimal for 
a surgical procedure unless it prolongs for more than three hours. 
 
  
 
It is not advisable to use the antibiotics for a prolonged period due 
to multidrug resistant strains emergence.  
                                                                                                                                                           
Undue fear in surgeons minds? 
             Surgical-site infection (SSI) rate in clean surgeries and clean 
contaminated surgeries are 2% to 5% and upto 20% respectively. 
Usually prophylaxis is not used for clean surgeries. But prevalent usage 
of prophylactic antibiotics in these clean procedures is due to the undue 
fear of infection in the minds of majority of our surgeons. Appropriate 
usage of antibiotics gains paramount importance due to emergence of 
multi drug resistant strains. 
 
 
 
                   
 
 
 
 
 
 
  
 
AIMS AND OBJECTIVES 
 
                  The objective of the study was to evaluate the role of 
prophylactic antibiotics to prevent surgical site infections in clean and 
elective surgeries.  
Surgeries included in the study were: 
 Hernia repair 
 Open  hernioplasty 
 Laparoscopic hernioplasty                                  
 Neck 
 Thyroid surgeries 
 Lipoma nape of neck 
 Breast 
 Modified radical mastectomy 
 Excision biopsy 
 Scrotal surgeries 
 Hydrocele 
 Epididymal cyst excision 
 
 
 
  
 
PROPHYLACTIC ANTIBIOTIC VS NO ANTIBIOTICS:  
 
                To compare the surgical site infection in two groups of 
patients,  
• one receiving prophylactic antibiotics (Study group) and 
• the other group without any prophylaxis before surgery. 
(Control group) 
 
 
 
 
 
 
 
 
 
 
  
REVIEW OF LITERATURE 
Historical background: 
As surgeons, though we deal with infections since the dawn of 
time, our understanding to treat wound infection became clear only after 
the development of theory of antisepsis and the evolution of germ 
theory. Many observations made by nineteenth century physicians were 
crucial in our knowledge regarding the pathophysiology, treatment and 
prevention of surgical site infections. 
Louis Pasteur formulated germ theory and elucidated that 
contagious diseases are caused by specific microbes. With the help of 
these principles, he pioneered techniques of sterilization. Also, he 
identified certain organisms responsible for human infections like 
Staphylococcus, Streptococcus, and pneumococcus. 
Joseph lister used a solution of carbolic acid, which were used to 
treat sewage in his times in Europe, to dress the patients. As this reduced 
the post operative infection incredibly, it was quickly adopted 
throughout his country. 
In 1880, Robert Koch, through his experiments identified 
pathogenic organisms associated with specific disease like cholera and 
tuberculosis. 
  
Charles Mc Burney pioneered the principle of source control (i.e, 
surgical intervention to eliminate the source and thereby treat the 
infection) by performing appendicectomy as treatment of appendicitis, 
which was previously known to be a fatal disease. This was popularised 
after been performed on the King Edward VII of England, by Sir 
Frederick Treves. 
              The discovery of effective antimicrobials helped the modern 
surgeons to treat wound infections in a much better way, during the 
twentieth century. During world war I, Sir Alexander Fleming, an army 
medical officer in British Medical Corps identified the first antibacterial 
agent Penicillin through his works on the natural action of blood against 
bacteria and sepsis. During his study on influenza virus, in 1928,  he 
noticed a zone of inhibition around Penicillium notatum  colony  that  
grew profusely on a plate of Staphylococcus.  He then named the  
substance derived as ‘penicillin’.  
           This subsequently led to the development of hundreds of potent 
antimicrobial agents against infectious organisms, which set an example 
for their use as prophylaxis  against  postoperative  wound infection, and 
became a very crucial  component in the treatment  of aggressive and  
potentially fatal  surgical  wound infections. 
  
         Prolific advances in the field of clinical microbiology paved way 
for the discovery of many new anti microbial agents against those 
microbes. Also the discovery of autochthonous microflora of skin, 
respiratory tract, alimentary tract helped modern surgeons to enhance 
their knowledge about  the organisms which will be encountered during 
surgery. However, whether these organisms were pathogenic or non 
pathogenic remained unclear. 
          With clinical observations made by veteran surgeons, Frank 
Meleny and William Altemier, the fact that aerobes and anaerobes 
synergise to cause serious infections (soft tissue infections and 
intraabdominal sepsis) came into limelight. So the concept that 
inhabitant microorganisms were not pathogenic to human body was 
vanished as these organisms have the potential to cause surgical 
infections when entered into sterile cavity during the time of surgery. 
Over the few last decades, new ideas of polymicrobial nature of surgical 
infections were propagated. Aspirates from the peritoneal fluid of 
patients with perforated viscus or gangrenous appendicitis also showed 
the presence of aerobes and anaerobes.  Trials were conducted to know 
the effective source control to treat these infections and antimicrobial 
agents were administered targetting both pathogens and commensals.  
  
     William osler, one of the pioneers of American Medicine, from his 
observations noted that patient died due to inflammatory response in the 
body to a organism. This allowed our insight into the host inflammatory 
response to infection. It is because of activation of multiple pathways in 
response to an infection. So many new therapies were formulated 
tagetting the modified inflammatory response. Exaggerated 
inflammatory response seems to be the cause of end organ failure and 
multi organ dysfunction. Thus, treating surgical infections and thereby 
preventing multi organ failure is one of the challenges faced by surgeons 
like us. 
PATHOGENESIS OF INFECTION: 
Host defences:  
 Barrier 
 Microbial flora 
 Humoral responses 
 Cellular responses 
 Cytokine production                                   
Defense barriers: 
 Physical barriers 
  
 Chemical barriers 
 Immunologic barriers 
Mammalian host possesses intrinsic defense mechanisms that help 
to prevent invasion of microbes, multiplication of organisms and 
thereby cause containment of infection. Our host defences are highly 
regulated system and are very effective in coping the invaders. They 
include:- 
1. Site specific defences  (SSD) 
2. Systemic defenses 
Site specific defenses provide protection at tissue level.  
Systemic defences begin immediately after invasion of pathogen 
into sterile area of body. 
Any micro organism will have to face number of barriers in the 
body. 
1. Epithelial barrier 
2. Mucosal barrier. 
          Mucosal barriers provided by mucosa of respiratory, 
gastrointestinal and urogenital system.  
  
          Host barrier cells prevent invasion of microbes and  proliferation 
by secreting certain substances. Skin commensals adherent to surface 
preclude virulent organism invasion, thereby forming colonisation 
resistance. 
PHYSICAL BARRIERS: 
Skin: 
   Skin, the largest organ in the body provides most extensive 
physical barrier. Resident or commensal microflora on the surface of 
skin block the attachment of pathogens. Some of the endogenous 
microflora include staphylococcus, streptococcus, corynebacterium, 
propionibacterium species. Also, Enterococcus faecalis, Enterococcus 
faecium, Escherichiae coli, Enterobacteriacae and Candida albicans are 
isolated from skin surface below the umbilicus. Skin diseases can be 
associated with abnormal proliferation of skin commensals. 
Respiratory tract: 
            Host defences in respiratory tract help to maintain sterile 
environment in distal bronchi and alveoli under normal circumstances. 
Larger particles are trapped in the mucosa of respiratory tract which are 
later cleared through cough. Smaller particles reaching the lower 
  
respiratory tract are cleared by pulmonary macrophages through 
phagocytosis. Any breach in this process leads to bronchitis or 
pneumonia. 
Gastrointestinal tract: 
         Numerous microbes are encountered in many portions of gastro 
intestinal tract. Places where resident microflora are absent include 
urogenital, biliary and pancreatic ductal system under normal 
circumstances. However, in case of inflammation, malignancy, stone 
formation or catheterisation, microorganisms may proliferate. 
          Vast number of micro organisms are found in oropharynx and 
colorectal region. But, organisms found in entire gastro intestinal tract 
are not always from oropharynx. It is because of the following reasons: 
1. Highly acidic environment in stomach kills the microbes. 
2. Low motility in stomach during initial phases of digestion. 
Thus, microbial population in stomach accounts to approximately 
102 to 103 colony forming units (CFU). But this may be increased during 
disease states or drug intake. 
  
In terminal ileum, microbial proliferation occurs, increasing count 
to approximately 105 to 108 CFUs. Exponential growth occurs in colon 
due to its relatively static and hypoxic environment, where aerobic 
species are outnumbered by anaerobic organisms to approximately 10: 
1. 
FIGURE 1 MICROFLORA IN GASTROINTESTINAL TRACT 
 
 
  
    Part of GIT Microbial population(CFU/ ML) 
Stomach 102  to 103 
Small intestine  105  to 108 
Distal colorectum 1011  to 1012 
Along with facultative and obligate anaerobes like Bacteroides, 
Lactobacillus, Clostridium, Fusobacterium and Eubacterium, some 
aerobic microbes like Escherichia coli, Enterococcus faecalis, 
Enterococcus faecium, Enterobacteriacae and Candida albicans are also 
present in the colon. These organisms provide colonisation resistance 
and prevent the entry of other organisms like Vibrio cholera, Shigella, 
Salmonella. But when pathology like perforation occur, the commensal 
organism provide nidus of infection for the pathogens to proliferate. 
Surprisingly very little host organisms contribute to the intra abdominal 
infection.  
When pathogens enter specific body compartments or tissue, 
defense mechanisms act to eliminate or remove the nidus of infection. 
Apart from providing physical barrier, certain proteins like  
1. Lactoferrin and Transferrin sequester microbial growth factor iron. 
2. Fibrinogen in inflammatory fluid trap micro organisms and 
polymerises to fibrin. 
  
3. Diaphragmatic pumping mechanism on the undersurface of 
diaphragm help in expunging micro organisms from peritoneal 
fluid. 
4. Omentum, ‘the policeman of abdomen’ serves to limit infection. 
Immunologic barriers:- 
Defense mechanisms in tissues of the body ;- 
a) Resident macrophages regulate cellular host defense. 
b) Secretion of cytokines is upregulated by substances like TNF – 
alpha, IL- 1 beta and INF Gamma. 
When microbes interact with defense mechanisms in body, 
opsonisation occurs. Extracellular destruction of organisms occur by 
formation of membrane attack complex and intracellular destruction by 
formation of phagocytic vacuoles. 
Complement pathways, both alternate and classical pathways get 
activated after microbial invasion. Release of complement fragment 
(C3a, C4a, C5a) increases vascular permeability. When microbial insult 
occurs, chemotaxis (i.e., attraction of neutrophils to the micro organisms 
to the site of insult) occurs. This further leads to the influx of 
  
inflammatory fluid to the area of insult. Diapedesis of neutrophils occur 
within minutes and it peaks within a period of hours or days.  
 Response to an infection depends upon several factors: 
1) Number of micro organisms entering the body. 
2) Proliferation of organisms 
3)  Virulence of organisms 
4) Potency of defense mechanism 
Invasion of microbes can lead to one of the following possible 
outcomes. 
a) Eradication of infection 
b) Limitation of infection ( purulent infection is the hall mark of 
chronic infection) 
c) Locoregional infection (cellulitis, soft tissue infection) 
d) Systemic infection (bacteremia) 
Infection is defined as an ‘identification of microorganisms in host 
tissue or bloodstream, plus an inflammatory response to their presence’. 
The inflammatory signs of ‘rubor, tumor, calor, and dolor’ are common, 
at the site of infection. Apart from these local manifestations, certain  
systemic manifestations like increased pulse rate and respiratory rate, 
  
elevated temperature and elevated white blood cell (WBC) count. 
Above noted systemic manifestations comprise the ‘systemic 
inflammatory response syndrome ‘(SIRS). 
 
Fig 2.  Causes of SIRS 
“Sepsis is not an antibiotic deficiency syndrome” 
SIRS when it is caused by microbial infection is termed as sepsis 
and it is mediated by production of a cascade of numerous 
proinflammatory mediators produced in response to the products of 
microbial invasion. These products can be a lipopolysaccharide 
(endotoxin) derived from gram-negative bacteria; or a peptidoglycan 
and teichoic acid from gram-positive bacteria; multiple fungal cell wall 
components such as mannan and numerous others. Patients have sepsis 
  
if they meet the following  clinical criteria for SIRS and have an evident 
local or systemic infection. 
              Severe sepsis is defined as sepsis  along with the occurence of 
new-onset  failure of organs. It is the frequent cause of death in surgical 
intensive  care units, with a very high mortality rate. i.e., when  a patient 
with sepsis  needs  ventilatory support and is unresponsive to fluid 
resuscitation or one who requires vasopressors to correct hypotension, is 
considered to have  severe sepsis. 
               Septic shock is a state in which patient has acute circulatory 
failure which is usually identified by the occurence of persistent  
hypotension (systolic blood pressure <90 mmHg) inspite of aggressive  
fluid resuscitation, with no other identifiable causes. It is the severe 
manifestation of infection. It can occur in approximately 40% of patients 
with severe sepsis; with a very high mortality rate. 
 
 
 
 
 
  
PATHOGENS OF INTEREST FOR SURGEONS: 
1. BACTERIA 
These are little organisms which are of great importance for the 
surgeons, as they form the vast majority of surgical site infections.  
Cell wall staining: 
 There are a number of species of bacteria which are identified by 
a specific staining called Gram’s stain. 
 This staining imparts specific colour to bacterial cell wall through 
which it is classified as gram positive and gram negative. 
a) When they stain blue, they are termed as gram-positive 
bacteria. 
b)  And when a bacteria stains red, it is termed as gram-
negative. 
Growth characteristics: 
• Every bacteria have certain specific growth characteristics 
in its specific media.   
•  Based on a number of some characteristics, bacteria can be 
further classified.  
 
 
  
It can be depending on 
a) Morphological characteristics 
 
  
 
b) the pattern of multiplication [e.g., single or multiplication in 
groups of organisms, i.e., in pairs (diplococci) or in clusters 
(staphylococci), or in chains of organisms. (streptococci). 
 
c)  and the presence  of spores and its location. 
 Terminal spores 
 Subterminal spores 
Gram +ve 
cocci 
Gram –ve 
bacilli 
  
Gram-positive bacteria  
      The bacteria that cause surgical site infections  are: 
a) skin commensals  
 Staphylococcus aureus and 
 Staphylococcus epidermidis and  
 Streptococcus pyogenes and 
These organisms cause infections either alone or in combination 
with other pathogenic organisms. 
b) commensals of GIT such as 
     Enterococci faecalis and  
    Enterococci  faecium.  
They have the capability to cause nosocomial infections like 
respiratory infections, catheter associated infections urinary tract 
infections (UTIs) and septicaemias in immunologically compromised or 
chronically debilitated patients. But in healthy individuals, these are of 
little importance. 
 
  
Gram-negative bacteria: 
The organisms which a surgeon specially interested among gram 
negative species include: 
 E. coli,  
 Proteus vulgaris and mirabilis 
 Klebsiella pneumoniae 
 Serratia marcescens 
 Pseudomonas aeruginosa,  P. fluorescens. 
 Enterobacter 
Anaerobic organisms  
• These organisms are not able to multiply or divide  in the presence 
of atmospheric air. 
• This is because of the absence of the enzyme catalase, which is 
important for the metabolism of reactive oxygen species. 
• They are the predominantly available in many areas of the human 
body, including oropharynx and colorectum among which flora in 
oropharynx is different from the one in colorectum. 
 
  
 C. Perfringens 
 C.difficile 
 C. tetani 
 C. Septicum or novyi. 
 Bacteroides fragilis 
 Propionibacterium  
 Fusobacterium spp. 
   Other bacteria of interest to surgeons include:  
 Mycobacterium tuberculosis 
 M. avium-intracellulare and M. Leprae. 
 Nocardia  
• These are acid fast and are very slow growing bacilli. 
• They are not easily cultivated in laboratory and need specific 
culture media to grow which may take several weeks to months. 
• They are notorious in causing severe pulmonary and extra 
pulmonary infections which is still prevalent in our country. 
Viruses:             
• Though small in their size, they cause wide variety of infections, 
especially in immunocompromised patients.  
  
• Mostly these organisms are intracellular. 
• They are extremely difficult to cultivate in artificial culture 
media.  
• They are usually identified by the presence of DNA and RNA 
using specific techniques in polymerase chain reactions. 
 Viruses of specific importance for surgeons include: 
 Hepatitis viruses B and C 
 Ebstein barr virus 
 Cytomegalovirus 
 Herpes simplex virus     
 Herpes zoster virus. 
Fungi 
• Fungi cause a number of nosocomial infections. 
• They are identified by special staining methods. 
• This can be 
 potassium hydroxide  
 Giemsa 
 India ink 
 methenamine silver 
  
• These can be present in yeast form, budding forms or can be 
observed with numerous branching along with septations. 
• They can cause surgical site infections combined with bacteria. 
• They cause severe infections in immunocompromised patients. 
• Fungi of interest to surgeons include: 
 C. albicans  
 Mucor 
 Rhizopus  
 Absidia spp 
 Cryptococcus neoformans 
 Aspergillus fumigates and A. niger, 
 Coccidioides immitis.                                                                       
SURGICAL SITE INFECTIONS 
NOMENCLATURE 
• DEFINITIONS: 
Earlier, the term, ‘Surgical Wound Infection Task Force’ 
(SWITF) was used to ascribe surgical site infections. 
The term ‘SURGICAL WOUND’–was replaced by  ‘SURGICAL 
SITE INFECTION’. This term was formulated by CDC in 1992. 
  
 
Figure-3  Classification of surgical site 
infection
 
 
 
Figure-4   Superficial SSI 
  
CATEGORIES OF SSI 
 SSI were categorized into two, 
1. Incisional SSI  
» Superficial  
» Deep 
2. Organ/space SSI. 
          Of surgical infections, 60 to 80% are incisional and the  
remainder are organ/space infections. 
SUPERFICIAL SSI 
A superficial SSI can be defined as ‘An Infection occuring within 
30 days of surgery and it involves only the skin and subcutaneous tissue 
of incision’. 
It includes: 
• Purulent aspirate from the site of incision associated with or 
without positive culture 
• Local signs of infection and inflammation  –  pain, tenderness, 
localised swelling, redness, heat and this is usually followed by  
  
 
 
 
 
FIGURE 5 DEEP INCISIONAL SSI 
 
FIGURE 6 DEEP INCISIONAL SSI 
 
  
• deliberate opening of the superficial incision by surgeon, unless 
the results of culture reports are negative. 
• Micro organisms obtained  from the culture of fluid or tissue taken 
aseptically from a superficial incision 
• Diagnosis of superficial  infection made by the surgeon 
     Conditions which should not be considered as SSI include: 
              1.  Stitch abscess 
              2.   Episiotomy wound   
              3.  Infection at the site of circumcision in a new born child. 
               4.  Infected burn wound                                                                                                          
DEEP INCISIONAL SSI 
          Deep incisional SSI can be defined as ‘An Infection that is  
occurring within 30 days of surgery ( 1yr if an implant is in place) and 
infection involving deep soft tissues. 
         It usually  includes: 
• Purulent discharge from the site of  deep incision. 
• Fever of 38 degree celsius or More. 
  
• Local pain / tenderness at the incision site and incision dehisces 
spontaneously  or is opened deliberately. 
• Abscess or other evidence of infection which involves the deep 
incision and found on direct examination / visual / radiological / 
histological examination. 
•    Diagnosis made by the physician / surgeon. 
ORGAN / SPACE SSI 
         An organ or space SSI can be defined as ‘An Infection occuring  
within 30 days ( 1yr of implant ) or Infection involving any other part of 
the anatomy other than that of the incision site which was opened / 
manipulated at the time of surgery. 
       It  may include :  
• Purulent  aspirate from the organ / space operated which is 
identified by a drain 
•  Micro organisms  from the culture obtained aseptically 
•  Infection identified during reoperation / Histological  
examination/ imaging. 
 
  
•  ORGAN SPACE SSI MASQUERADING INCISIONAL SSI 
        The following organ space surgical site infection pretends to be an 
incisional SSI. 
• Imaging studies done to rule out subfascial collection / fistula 
from hollow organs. 
• Presumptive usage of systemic antibiotics. 
• Interventional radiology/ re-operation done. 
• Trigger the lethal MOF( multi organ failure). 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
FIGURE 7 DEEP/ORGAN SPACE SSI 
 
 
 
 
 
  
CLASSIFICATION OF SURGICAL WOUND INFECTION: 
CLASS – I    :    Clean wound  
     (Expected wound infection rate is 1-3%) 
Definition:-          
 -    Atraumatic wound   
           -  There are no signs of  inflammation 
 -   Gastrointestinal, Respiratory, Genito Urinary, Biliary  
       tracts are not entered. 
Organisms :--         Staphylococcus aureus, Staphylococcus   
   epidermidis  
Example:--              Hernia repair, Breast surgeries, Thyroid surgeries. 
CLASS – II :– 
         Clean contaminated 
         (5-10% expected infection rate) 
Definition :-    
Elective operation of GIT, Genito Urinary, respiratory tract    
have been entered during surgery under controlled conditions 
  
Organism:--   Endogenous micro flora of the organ that has been entered 
Example:--   Cholecystectomy,  Elective bowel resection 
CLASS – III: 
CONTAMINATED WOUNDS 
( Expected infection rate is 15%) 
Definition :--    
traumatic wounds(fresh) 
any  breach in the sterile       
 technique used 
Gross spillage from Gastrointestinal tract 
Acute non purulent inflammation 
Organism  :--  Endogenous bacteria 
Example  :-  Appendicectomy  
CLASS  - IV 
     DIRTY WOUND 
     (Expected infection rate is 40%) 
 
  
Definition :--  
Old traumatic wounds 
Devitalized tissue 
Gross purulence  
Pre existing infection 
Perforated viscera 
Example    :--     Hartmann's operation for perforated diverticulitis 
RISK FACTORS: 
•  Rate of SSI is dependent on several variables like 
1. Patient  
2. Type of surgery 
3. Perioperative environment 
4.  Type of pathogen 
RISK of SSI =  dose of contamination   x   virulence  
                                          host resistance 
             CDC SENIC (Study of  effect of  nosocomial infection 
control) describes about the predictive index for a surgical site infection.                   
  
 The  following four factors are being considered:-- 
1) An Abdominal operation 
          2) An operation that lasts longer than 2 hrs 
3) An operation that is contaminated 
4) A patient who will have three or more diagnosis at the time of 
discharge exclusive of wound infection 
The patients are given a score of 0 or 1 for the above said variables. 
               SENIC SCORE 
 
 
 
 
 
 
 
 
Score % of infection 
0 1% 
1 3 – 6% 
2 9% 
3 17% 
4 27% 
  
NNIS risk index 
(National Nosocomial Infection Surveillance) 
NNIS framed the following variables for risk index in surgical site 
infection. 
• ASA score                 –    3 or more 
• Length of operation    –    75th  percentile of its duration  to a 
 particular surgery                  
• Level of contamination  –    contaminated/ dirty 
The risk factors associated with surgical site infection can be: 
I. ENDOGENOUS FACTORS 
II. EXOGENOUS FACTORS 
Endogenous(patient related) factors: 
This includes: 
1. Duration of pre operative stay of a patient in the hospital 
2. Presence of  any previous infection in patient (I A) 
3. History of previous Abdominal operation 
4. Age of the patient >50 years  or < 1 yr 
  
5. An Obese patient 
6. History of Diabetes Mellitus in patient (I B) 
7.  Immunocompromised state or Malnutrition 
8. Altered immune response 
9. Usage of Tobacco  – (I B) 
Exogenous (Perioperative factors): 
The exogenous risk factors which also contribute to surgical site 
infection include the following: 
• Prophylactic Antibiotic given to the patient before a surgery  or 
procedure. 
• Period or length of surgery – if the duration exceeds more than 
3hours, additional dose of antibiotic must be given 
•  Ventilation of an operating room 
• Technique handled by the operating surgeons – usage of cautery 
cautery, obtaining perfect haemostasis, trauma  (IB)   
• Asepsis and Proper sterilization of instruments 
  
• Length and duration of surgical scrub using betadine or alcohol 
(2-5mts) 
• Antisepsis of skin (I B) Though removal of hair is controversial in 
causing SSI, it may contribute to SSI (IA) 
• Presence of a foreign material in the surgical site 
•  showering of a patient before surgery( I B) 
• Usage of Surgical drains(guidelines) 
SURGICAL WOUND SITE SURVEILLANCE:  
Surveillance of wound site is usually done by 
a)  sterile dressing for 24-48hrs after surgery (IB) 
b) washing hands before and after changing dressing (IB) 
c) usage of sterile technique for dressing (II) 
 
 
 
 
 
  
MEASURES TO PREVENT SSI: 
 
FIGURE 8 MEASURES TO PREVENT SSI 
Pre-operative measures 
 
FIGURE  9 PRE OPERATIVE MEASURES 
  
PREPARATION OF PATIENT : 
               Before preparing the patient for an elective operation, the 
following steps must be undertaken.  
  Identify and treat infections away from the surgical site before 
operation. 
 Keep the pre-operative stay as short as possible 
 Proper control of blood glucose levels 
 Ask the patient to take a bath before the surgery.  
 Do not remove hair unless it interferes with operation and if 
required, remove with electric clippers immediately before 
operation. 
 Abstain From any forms of  tobacco or alcohol consumption  
prior to operation 
 Apply antiseptic agent in concentric circles moving towards 
periphery. 
PREPARATION OF THE OPERATING TEAM 
1. Nails should be kept clean and  short   
2. Surgeon should not wear any rings or hand jewellery 
  
3. Preoperative surgical scrub for 5 minutes 
4. Scrub the hands till elbows for a surgical hand washing 
5. Water should always flow from hands towards elbow after a scrub 
  6.  Always use a  towel,  gown and gloves which is sterile 
How to manage when a person in surgical team is infected? 
 Educate  them to report to the team head   
 Developing well-defined policies concerning patient care  
 Surgical personnel with  draining skin: 
 Must provide and collect cultures 
 Abstain from duty, until infection has been subsided 
  or adequate antimicrobial therapy  provided  
Principles of prophylaxis: 
           Use of multiple methods (physical, chemical, and antimicrobial 
therapies) or a combination of these to decrease the presence of 
exogenous factors (surgeon and operating room environment) and 
endogenous factors (microorganisms) is called prophylaxis.   
 
  
Effective Source control: 
            The primary concept in the treatment of surgical site infections 
includes: 

 drainage of pus  

 wound débridement including infected and devitalized tissue  

 extrusion of foreign bodies  

 treatment of the  root cause of infection. 
Prophylactic antibiotic treatment  
          The usage of empirical antibiotics before a surgery or  during  and 
sometimes even after a surgery to prevent complications of infections. 
Therapeutic antibiotic treatment  
         The usage of substances that decrease the  growth or multiplication 
of organisms, which also includes its eradication . Thus, it reduces 
infection caused not only by a pathogen but also the infection caused by 
the organism  which colonises a gut or skin of the  patient.         
Antibiotic Prophylaxis: 
        Antibiotic prophylaxis was first proposed by Miles and Burk in 
1950. 
  
Prophylaxis should be planned so that it is administered at the 
time of induction or skin incision.  Because, 
• after 3 hrs of  entry of infectious agent, it becomes  very 
ineffective. 
• Concentration of organisms > 100,000 / gm of tissue usually 
exceed the capacity of host defense.  
•  In the body, Humoral or cellular mechanisms defeat bacteria. 
What are the Principles behind prophylaxis 
• Always use the antibiotic agent which is likely to cause the 
probable infection 
• Use full dose of any antibiotic chosen 
• Administer the chosen  drug  prophylactically  
• If duration of operation is  prolonged for more than 3 hrs, give 
another dose of the chosen antibiotic. 
• Employ post operative antibiotic, when the risk of infection is 
increased. 
“The consensus is that a single dose of antibiotic  immediately before  
an operation is enough and that there are dangers not only to  hospital 
  
but also to the patients in prolonged course of prophylactic antibiotics. 
Resistance to antibiotics is related closely to the prolificity with which 
antibiotics are prescribed” 
Single dose prophylaxis 
 In 1977, STRACHAN and his colleagues first proposed single 
dose antibiotic prophylaxis. They proposed single dose of broad 
spectrum antibiotic prior to surgery without any usage of it after the 
procedure. 
Trial of single dose vs no antibiotic: 
In one of the study conducted, comparison was done between 
single dose of preoperative antibiotic (cefazolin) against  5 days of post 
operative treatment of the same. Infection rate of prophylactic group 
was about 3% and in the other group where post operative antibiotic was 
given the infection rate was 5%. 
Trial of Single dose vs. Multiple dose  of antibiotics:     
Comparison was done between patients undergoing Colonic 
surgery receiving single dose of prophylactic antibiotic against multiple 
doses of antibiotics. Out of 510 surgeries done in single dose group, 
  
infection rate was 4.3% and in the group of 493 patients who received 
multiple doses of antibiotic, the infection rate was 6.9%. 
 Results of  27 studies conducted were as follows:  
 Single dose Multiple doses 
operation 510 493 
infection 22 34 
Rate of infection 4.3% 6.9% 
    
Antibiotic prophylaxis and its possible risks? : 
           Patients with a history of allergy, urticaria or pruritic rash, 
bronchospasm, hypotension, local swelling, laryngeal oedema occurring 
even after a single dose of penicillin injection have a potential risk of 
anaphylaxis (type I immediate hypersensitivity). So recommendation of 
 beta-lactams as a prophylactic antibiotic is highly condemnable. 
           For patients with allergy to penicillins or cephalosporins, 
alternative antibiotics, according to the nature of infection, has been 
formulated. These  are  very important as far as the patient’s safety is 
concerned, failure of which may lead to a disaster.  
D      
   
  
 WHO Model List  – 2003 
           This list contains only 25 essential antibiotics for controlling  
most of the surgical site infections. 
             For routine use – 19 antibiotics were recommended. 
             For complementary use – 6 have been recommended. 
 NARROW SPECTRUM AGENTS 
• Gram positive agents include: 
    Penicillin 
    Cloxacillin  
    Erythromycin 
    Clindamycin  
    Vancomycin  
• Gram negative  
         Gentamycin  
         Ciprofloxacin                                                                                                            
         Spectinomycin  
         Nitrofurantoin  
         Nalidixic acid 
  
         Ceftriaxone  
         Ceftazidime  
• EXTENDED SPECTRUM ANTIBIOTICS 
          It includes antibiotics for both Gram + ve and Gram –ve 
organisms. 
Ampicillin  
Amoxycillin  
Cotrimoxazole  
Trimethoprim  
Sulphadiazine  
Amoxicillin + clavulanic acid 
Imipenam +cilastatin  
    BROAD SPECTRUM ANTIBIOTICS 
Doxycyclin  
Chloramphenicol  
     For Anaerobic infections: 
• Metronidazole  
 
  
When to administer Antimicrobial prophylaxis ? 
Administer the antibiotic by an intravenous route 
How to administer? 
 a) Prophylaxis must be planned such that maximum bactericidal 
concentration of the agent reaches the serum and the tissues while 
putting an incision on the skin.  
  b) Also it is important to maintain the serum concentration  of 
the drug till the surgery is over. 
 
• Agent  • Initiation of 1st dose  
• Most antibiotics  • Within 60 minutes 
before incision  
• fluoroquinolone or 
vancomycin  
• Within 90-120 
minutes before 
incision  
 
 
 
  
 
Prophylactic Use of Antibiotics 
 
Site Antibiotic Alternative (e.g., 
penicillin allergic) 
Cardiovascular 
surgery 
Cefazolin, cefuroxime Vancomycin 
Gastroduodenal area Cefazolin, cefotetan, 
cefoxitin, ampicillin-
sulbactam 
Fluoroquinolone 
Biliary tract with 
active infection 
(e.g., cholecystitis) 
cefaperazone-sulbactam, 
piptaz and  clavulanic acid 
with ticarcillin  
Quinolone group with 
metronidazole or 
quinolones along with 
clindamycin  
Colorectal surgery, 
obstructed small 
bowel 
Cefazolin plus 
metronidazole, ertapenem, 
ticarcillin-clavulanate, 
piperacillin-tazobactam 
Gentamicin / 
fluoroquinolone plus 
clindamycin or 
metronidazole 
Head and neck Cefazolin Aminoglycoside plus 
clindamycin 
Neurosurgical 
procedures 
Cefazolin Vancomycin 
Orthopedic surgery Cefazolin, ceftriaxone Vancomycin 
Breast, hernia Cefazolin Vancomycin 
 
  
(Courtesy:  Schwartz principles of surgery 9
th
  edition) 
 
Timing of Antimicrobial Prophylaxis 
  According to a Prospective Observational study conducted, 
Consecutive surgical patients were studied over a 1 year period which 
included 3836 various surgeries performed. 
All patients received 1.5g cefuroxime as antimicrobial 
prophylaxis during the study. 
In all the osteosynthesis operations been done, additional 0.75g 
cefuroxime at 8 hours and 16 hours after a  initial dose of antibiotic. 
• Doses were adjusted in patients with renal failure. 
• The exact timing in minutes was recorded. 
• Incidence rates of SSI were recorded 
 
                                       Minutes before incision 
ssi 
  
    
According to that study,   
• When antibiotic was administered 0 to 30 minutes before 
incision,  P value was  < 0.001.  
• When the same was administered 60 to 120 minutes before 
incision, the reported  P value was equal to  0.035. 
• Hence it was concluded that it is better to give prophylaxis half 
an hour before any surgical procedure. 
 
 
                       
 
 
 
 
 
 
  
 
Intra-operative measures to prevent SSI 
 
FIGURE 10Intra-operative measures to prevent SSI 
Ventilation in Operation Theatre 
  
• It is very important to maintain ventilation in operative theatres as 
it is essential step to prevent surgical site infection intra 
operatively. 
• There are certain criteria which include: 
 Air cycles flow inside the theatre must be a minimum of 5  per 
hour [atleast 3 fresh air] 
 The  recirculated air must  pass first  through an appropriate 
filter and then flowed into the operating room. 
 positive pressure must be maintained in operation theatre with a 
comparative negative pressure outside the area  
 Always it is preferable to Keep the door closed unless when  
needed for passage of persons inside the room. 
  Always the passage of air must be Air from  the ceiling and the  
exhaust must be near  the  floor of the theatre. 
 Except for the surgical operating team, the number of persons 
inside the theatre must be kept to a minimum. Next is an 
important point to remember as it is not advisable to use UV 
rays inside the operating room to prevent infection 
Cleaning and disinfection of environmental surfaces 
  
 When the theatre is soiled or contaminated, use appropriate 
antiseptic or antibiotic for cleaning before next surgery 
  Never close the theatre without cleaning  after a  contaminated 
or dirty operation. 
Microbiological Sampling 
 sampling of the operating room must be performed on a regular 
basis 
 surgical instruments must be sterilized periodically according to 
specific guidelines 
 Flash sterilization is done for the instruments that must be used 
immediately after a previous surgery 
 Never do flash sterilization on a routine basis and it is always 
advisable to keep an additional set of instruments for emergency 
purposes. 
Surgical attire and drapes 
 Cover the  nostrils and mouth using a mask inside  the theatre 
 Until the surgery is over, it is essential to wear a mask. 
  
 Cap that is worn must fully cover the hair of the surgeon and 
assistant. 
 Gloves used must be sterile. 
 Gloves are wore after surgical draping 
 Contaminated or a visibly unsterile surgical gowns must not be 
worn and always discarded 
 Strict aseptic technique must be maintained.  
 It is important to thoroughly wash the wound so that devitalized 
or dead tissue is effectively debrided.  
 Foreign body when present must be removed immediately. 
 Perfect hemostasis must be maintained 
 It is advisable that a heavily contaminated wound is left open and 
is allowed to close by secondary intention. 
 It is essential to maintain wound hygiene. Post-operative care of 
the incision must be done and kept clean  
 
 
  
 
 
 
Figure 11  -  Wound Surveillance measures 
 
Surveillance 
  standard definitions must be used to define and categorise  SSIs 
 Classification of wound must be done at the end of operation. 
  
 Operating surgeon must be informed of the type and classification 
of infection 
 Surveillance of the wound may be required even after the 
discharge of the patient and followed up regularly. 
• According  to Hospital Surgical Surveillance Programme, Strict 
CDC definitions must be used to classify the wound 
• Most of the  patients are not  admitted to the hospital 
• When discharged in the early post op period, patient must be 
asked to follow up in the outpatient department till 30 days of 
surgery 
• Appropriate number of nurses specially trained to identify 
infection control must be allotted 
• Periodical reporting of infection rates must be done.   
Innovative Strategies to Reduce Infection Within the hospital 
Environment 
Though there are studies that show results of decrease in infection 
rates with the usage of impregnated technologies, it is not been proved 
beyond doubt of its significance. 
  
      Thus the impregnated technologies used is of doubtful value. 
“Antibiotic for the fool is a tool which appears cool. But somebody 
pays the price as a rule” 
 
Postoperative Nosocomial Infections 
 Postoperative Nosocomial Infections include: 
 Respiratory infections  
 Urinary tract infections 
 Surgical site infections and 
 Septic episodes. 
 Nosocomial infections are due to usage of catheters, 
instrumentation, intra venous and intra arterial access (venflons) 
and central venous pressure lines. 
 UTI is confirmed by demonstrating WBCs or bacteria in routine 
urine examination or  a positive test for leukocyte esterase, or a 
combination of these two. 
 Table- UTI confirmation 
patients Culture value of organism 
  
obtained 
symptomatic patients >104 CFU/mL 
asymptomatic individuals >105 CFU/mL 
 
 It is important that urinary catheters be removed as quickly as 
possible within24 to 48 hours, as long as they are ambulant. 
 Pneumonia may be due to prolonged mechanical ventilation and 
is due to pathogens common in the hospital atmosphere. 
 Hospital-acquired pneumonia is diagnosed by the presence of a 
purulent sputum, leukocytosis, fever of very high grade and  chest 
x-ray changes. 
 Bronchoalveolar lavage must be done to obtain samples and the 
material is subjected to Gram's stain and culture to identify the 
microbes. 
  Weaning from mechanical ventilation  should be done as soon as 
possible.. 
 Most patients with intravascular catheter infections are 
asymptomatic, except for an increase in the blood WBC count. 
  
 Presence of the same organism in the blood cultures of a patient 
obtained from a peripheral site and  through the catheter tells the 
high index of suspicion.  
 severe sepsis or bacteremia due to gram-negative aerobes or fungi 
necessitates  catheter removal. 
  Catheter infections due to S. epidermidis can be effectively 
treated with a 14- to 21-day course of an antibiotic 
Post operative wound sepsis 
           Post operative wound sepsis continues to account for 14% of 
adverse events in hospitalized patients 
                Increases Morbidity,  
                Hospital Stay,  
                Expensive Antibiotic use and  
                Wastage of manpower 
The inability to deliver antibiotics to the under perfused tissue 
during surgery because of vasoconstriction, hypoxia and shock renders 
systemic post op antibiotics less effective 
Prophylactic antibiotics 
  
• Patients receiving pre-operative antibiotics had significantly fewer 
infections than patients receiving antibiotics either too early or 
postoperatively 
In order to avoid these problems, rational ANTIBIOTIC 
prophylaxis is designed to deliver the antibiotics to the undamaged 
tissue BEFORE CONTAMINATION occurs 
MECHANISM of PREOPERATIVE ANTIBIOTICS 
       Antibiotics preoperatively diffuse into the peripheral compartment 
and wound fluid 
This saturated antimicrobials kill and preventing the invading 
bacteria and bacterial multiplication 
GOALS OF ANTIBIOTIC THERAPY 
1.  To maintain the maximum concentration of agent  in the serum 
and also the tissues which is more than the MIC (minimal inhibitory 
concentration) by  3-4 times for not less than three quarters of time   
during surgery.  
    MIC – The minimum concentration of antibiotic to kill 99% of 
organisms. 
  
2.  Use full doses of chosen antibiotic in the DECISIVE period ( The 
vulnerable period during surgery) 
 
 
 
CHOICE OF ANTIBIOTIC 
1. Maintain effective antibiotic level throughout the procedure 
2. Less adverse effects 
3. Less interference with anaesthetic drugs 
  
4. Cost effective 
5. Broad spectrum to pathogens 
6. Less interference with host defense 
Antibiotics commonly used in the prophylaxis 
1. Penicillins 
2. Flucloxacillin and methicillin  
3. Ampicillin and amoxycillin  
4. Mezlocillin and azlocillin  
5. Cephalosporins 
6. Aminoglycosides 
7. Vancomycin 
8. Imidazoles 
9. Carbapenem 
10. quinolones 
THE ROUTE OF PROPHYLAXIS 
  
The route of prophylaxis will depend on the level of 
contamination. The preference of the surgeon and the reliability of the 
ancillary care. Both topical and parenteral administration have shown 
benefit in reducing wound infections when properly administered. 
 
TIMING 
        Most consistent timing was achieved with  iv  administration by the 
anesthetist  just  prior to induction of anesthesia or 30 min prior to the 
incision 
FOR PROLONGED PROCEDURES 
        Antibiotics should be repeated every 4 hrs 
        Antibiotics should be continued for 24-48 hrs postoperatively in 
clean contaminated cases 
       For dirty wounds, antibiotics should be continued for 5-7days 
INDICATIONS 
1.   Patients undergoing clean operations who are at risk ( ex. Patients 
undergoing hernia surgery with co- morbidities like diabetes 
mellitus, hypertension) 
  
2.  Prosthesis insertion (mesh repair in hernia surgery, insertion of 
drain in thyroidectomy or breast surgeries)  
3. Clean  Contaminated operations 
4.   contaminated operations 
 
TOPICAL ANTIBIOTIC PROPHYLAXIS 
Topical application consists of instilling antibiotic in the wound 
upon opening each tissue plane and at frequent intervals throughout the 
entire operation 
Only effective when they are constantly present on the surface of 
the wound ready to tackle the infective organisms Eg., 
Topical Sulfanilide on open fractures 
Topical Aminoglycoside  
In practice,  0.1 % solution of first generation cephalosporin is an 
excellent choice 
Aminoglycosides are frequently used but they have two  
disadvantages 
   a)   Systemic absorption leads to toxicity 
  
   b)   Anaerobes cannot be killed regardless of concentrations 
COMPLICATIONS 
The most feared complications are anaphylaxis and death 
Most commonly associated with the b-lactam antibiotics 
including the penicillins, cephalosporins, carbapenem and monobactam  
Vancomycin occasionally produces red man syndrome 
Cephalosporins can occasionally cause hypoprothrombinemia and 
bleeding. Nephrotoxicity and ototoxicity make aminoglycosides poor 
choice for prophylaxis 
They have ability to produce myoneural blockade and apnoea 
when given concomitantly with muscle relaxants particularly succinyl 
choline. 
Figure 12 – Side effects of prophylactic Antibiotics 
  
 
 
 
 
THE KEY TO SUCESSFUL PROPHYLAXIS 
Prophylaxis should be limited to perioperative administration 
only. 
A single perioperative dose or continuous administration if topical 
antibiotic is chosen 
Short course prophylaxis will be better 
Prophylactic antibiotics are not an excuse for poor technique 
  
 
 
 
 
 
 
 
 
MATERIALS AND METHODS 
 
Source of data: 
          Patients admitted to Govt. Rajaji hospital Madurai from June 
2011 to June 2012  for clean  general surgical operations were included 
with the consent obtained from the hospital ethical committee meeting 
conducted by the board members. 
 
Type of study: 
  
             Prospective interventional study 
 
 Sample size: 
             Totally 100 patients were selected. 
             Out of 100, 50 patients were allotted in study group and the 
remaining 50 in control group. 
              
Methods used for allocation: 
             Allocation of patients were done randomly. No specific 
selection of cases into study or control group was done. 
 
 
Inclusion criteria: 
Patients who had to undergo the following procedures were 
included. Hernia repair (open and laparoscopic approaches), breast 
surgeries (modified radical mastectomy for carcinoma breast and 
excision  biopsies for fibroadenoma breast), neck surgeries (total 
thyroidectomy for multinodular goitre and hemithyroidectomy for 
solitary nodular goitre, excision biopsy of  lipoma nape of neck) and 
scrotal surgeries (eversion of sac for hydrocele and excision for 
epididymal cyst).                                        
  
 
Administration of prophylaxis: 
 Study Group: 
         Injection Cefotaxim 1g IV was given 30 minutes before operation. 
 Control group:  
         No antibiotics were given pre operatively.  
• Similar techniques were followed for both groups to rule out any 
bias.  
• Strict asepsis were handled for both the groups. 
• Blinding (which prevents patients from allocation into specific 
groups) was done again to rule out bias. 
 
Exclusion criteria: 
 Patients who are diabetic, hypertensive or consuming medications 
for any other specific medical conditions 
 Patients who are Immunologically compromised 
 Patients who are Chronic malnourished 
 Patients undergoing contaminated or clean contaminated surgeries 
  History of fever, cough with expectoration 
 
Patients were examined for presence of  
  
• Erythema & Redness +/_ 
• Induration 
• Fever +/_ 
• Stitch Abscess / Granuloma +/_ 
• Wound gaping or discharge +/_ 
        
 Patients with above findings were investigated and Complete 
blood count and  Pus Culture & Sensitivity were sent. 
 Statistical analysis was done by standard statistical and clinical 
methods and data were analysed. 
 
 
 
OBSERVATION AND RESULTS 
Table-1 
SURGERIES INCLUDED IN STUDY 
S.NO. PROCEDURE STUDY CONTROL 
 
1 Hernia repair 
     open  hernioplasty 
     laparoscopic hernioplasty                                 
26 
23 
3 
25 
21 
4 
  
 
2 Neck 
      Thyroid surgeries 
       Lipoma nape of neck 
 
12 
6 
6 
11 
7 
4 
3 Breast 
      Modified radical mastectomy 
       Excision biopsy 
7 
4 
3 
8 
5 
3 
4 Scrotal surgeries 
       Hydrocele 
       Epididymal cyst excision 
        
5 
4 
1 
6 
5 
1 
6 TOTAL  50 50 
 
 
TABLE-2 
CASE DISTRIBUTION 
S. 
NO 
PROCEDURES STUDY GROUP 
 
CONTROL GROUP 
 
TOTAL 
 
1. HERNIA 
SURGERIES 
26 25 51 
2. NECK 
SURGERIES 
12 11 23 
3. BREAST 7 8 15 
  
SURGERIES 
4. SCROTAL 
SURGERIES 
5 6 11 
  50 50 100 
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PROCEDURES (STUDY GROUP)
52%
24%
14%
10%
HERNIA SURGERIES NECK SURGERIES
BREAST SURGERIES SCROTAL SURGERIES
 
 
PROCEDURES (CONTROL GROUP)
50%
22%
16%
12%
HERNIA SURGERIES NECK SURGERIES
BREAST SURGERIES SCROTAL SURGERIES
 
 
 
  
TABLE – 3 
AGE DISTRIBUTION OF PATIENTS 
Age Distribution 
Study Group Control Group 
No.of cases % No.of cases % 
 < 40 years 18 36 20 40 
 40 - 60 years 24 48 27 54 
 > 60 years 8 16 3 6 
 
                 
AGE DISTRIBUTION
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8
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0
5
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Table 4 
Sex distribution of patient 
Sex Distribution 
Study 
Group 
Control 
Group 
Male 37 34 
Female 13 16 
                               
 
Table-5 
WOUND INFECTION RATE OF PATIENTS 
 
Wound Infection 
Study 
Group 
Study 
% 
Control 
Group 
Control 
% 
SSI + 3 6 6 12 
SSI -  47 94 44 88 
 
P value  -  0.452   Not significant 
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Table – 6 
TYPE OF SSI 
                          
Type of SSI 
Study 
Group 
Control 
Group 
Superficial Incisional 2 4 
Deep Incisional 1 2 
Organ / Space  0 0 
 
 
 
2
4
1
2
0 0
0
0.5
1
1.5
2
2.5
3
3.5
4
Superficial
Incisional
Deep Incisional Organ / Space 
TYPE OF SSI
Study Group Control Group
 
 
 
  
TABLE 7 
ISOLATES FROM SSI 
 
Isolates from SSI Study Group Control Group 
STAPHYLOCOCCUS 
AUREUS 2 3 
KLEBSIELLA 
PNEUMONIA 0 1 
ESCHERICHIA COLI 1 1 
PSEUDOMONAS 
AERUGINOSA 0 1 
 
2
3
0
1 1 1
0
1
0
0.5
1
1.5
2
2.5
3
STAPHYLOCOCCUS
AUREUS
KLEBSIELLA
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AERUGINOSA
ISOLATES FROM SSI
Study Group Control Group
 
  
 
TABLE 8 
DURATION OF SURGERY 
 
 
Duration of Surgery 
Study 
Group 
Control 
Group 
< 1.5 hrs 36 23 
> 1.5 hrs 14 27 
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TABLE 9: 
POST OP STAY OF PATIENTS 
 
Duration of 
Post op Stay 
Study 
Group 
Control 
Group 
< 7 days 47 39 
> 7 days 3 11 
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QUICK  DISCUSSION AND SUMMARY 
         
               The term Clean surgeries describes the   procedures where in   
a sterile technique is strictly adopted and any of the tracts like GIT, 
respiratory and genitor-urinary tracts are not entered. 
             Apart from the factors like the operating team and the risk 
factors of the patient which contributes to the risk of infection, the 
operating atmosphere and the  sterility of the instruments and the effort 
which is taken to maintain asepsis also interferes with the rate of 
surgical infection. 
           It is rather not fair for a surgeon to prescribe an antibiotic when 
there is any breach in the technique of asepsis  as it is never  a substitute 
to asepsis. In a clean surgery, the infection is almost always entered the 
operative field from an exogenous source like skin of the patient or the 
nostrils of the operating team. 
 In this study the factors like hypertension, diabetes mellitus or any 
other co-morbities, immunocompromised state, malnutrition, previous 
surgeries, hypersensitivity to any antimicrobial agents have been 
excluded.  As per the literature, the rate of infection after a clean surgery 
is 1.5%  and is hardly more than 4%.  
  
According to the study performed in our institution, the rate of 
infection in the study group i.e., the patients who received a 
prophylactic antibiotic was 6%.  3 out of 50 patients developed an 
infection among which 2 had superficial incisional SSI. In the group 
who never received an antibiotic prophylactically, 6 out of 50 patients 
(12%) developed an infection of which 4 developed a superficial 
incisional SSI and the remaining deep incisional SSI. None of the 
patients in both groups developed an organ or space SSI.  48% of the 
patients in the study group and 54% of the patients in the control group 
were in the age group of 40 to 60 years with no significant co morbid 
conditions. 
 Organisms obtained from the isolates of patients from both the 
study group and the control group were predominantly staphylococcus 
aureus. Other organisms obtained were klebsiella pneumonia and 
escgerichia coli. The difference in the infection rate of both the groups 
was not significant statistically as the p value obtained from the chi 
square test was 0.452( p value becomes significant when it is less than 
0.05). This was actually similar to some studies performed in 
Rawalpindi, Pakistan  for a  similar set of clean and uncontaminated 
surgeries in a military hospital.    
  
   But according to Platt et al, who conducted a study to evaluate the 
use of perioperative prophylaxis in clean surgeries, there was an 
absolute decrease in the risk of surgical site infection to approximately 
50%. In this study, the sample size ( n = 1000 )  was sufficiently larger 
than our study.  More the number of procedures performed, more the 
sample size, more the power of study which makes the results of study 
considerably reliable. Also from such randomised trials performed the 
regimens for specific surgical infections can be devised.  
         Regimens usually successful are those which are 
a) Available at a cheaper cost to the patient. 
b) Remains in the serum for a longer time (half life). 
c) Considerable activity against organisms which are usually 
found in the nostrils and skin of the health care personnels. 
    Though the drug cefazolin serves the above purpose and been 
used nowadays for many clean and uncontaminated surgeries, the best 
agent for prophylaxis varies according to the type of surgery performed 
and  the likely source of infection. 
         Apart from the efficacy of the antibiotics used to treat or prevent a 
surgical site infection, the important factor which helps a surgeon to 
  
choose an antibiotic is its cost. Nowadays, antimicrobial agents have 
been misused in inpatient setup. This is also similar in an outpatient set 
up as ‘over the counter’ drugs. Antibiotic misuse gives an economic 
burden in a society due to increased costs in health care services. It also 
leads to newer infections like antibiotic associated diarrhoea caused by 
clostridium difficile. Emergence of multi drug resistant strains and 
organisms like “ super bugs” which are resistant to all but few anti 
microbial agents makes the already worsened situated more sober.  
             A responsible surgeon must weigh the potential risks and 
advantages of giving an antibiotic after a particular procedure, 
especially a clean and uncontaminated surgery where the chance of 
infection rate is very minimal and act accordingly.  
               Improvements in the quality of medical care can only be 
accomplished by proper usage of an antibiotic which is effective in 
preventing and controlling an infection. Optimal regimens for treating a 
surgical site infection must be tailored based on whom and what 
procedure  is been performed as it takes a heavy toll on the economy.         
 
 
  
CONCLUSION 
 
    According to the results of this study whish evaluated the role of 
prophylactic antibiotics to prevent surgical site infections in clean 
surgeries which included hernia repair (both open and laparoscopic), 
neck surgeries (thyroid surgeries and lipoma), breast surgeries (modified 
radical mastectomy and fibroadenoma excision) and scrotal surgeries 
(hydrocele and epididymal cyst excision), the rate of surgical site 
infection in the group which received prophylactic antibiotic (study 
group) was 6% and the one which did not receive any antibiotic prior to 
surgery developed 12% of wound infection rate. This difference in the 
rate of infection is not significant statistically as the p value was 0.452 
(>0.05) obtained by the test of significance (chi square test).       
            Thus we come to a conclusion that for a clean and 
uncontaminated surgery, the use of antibiotics prophylactically does not 
cause a significant reduction in the rate of surgical site infection. Also in 
literature, it is not established that prophylactic antibiotics for clean 
surgeries in general surgery reduce the infection rate as in clean 
contaminated and contaminated surgeries where its role is extensively 
studied and its reduction in rate of surgical site infection is strongly 
established. 
  
             Thus to conclude, according to this study performed, 
prophylactic antibiotics, unless warranted, has no significant role in 
clean elective surgeries. 
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PROFORMA 
ROLE OF PROPHYLACTIC ANTIBIOTIC TO PREVENT SSI IN 
CLEAN SURGERIES IN OUR UNIT IN GRH 
Name:       I.P.No : 
Age & Sex:       Unit  : 
Occupation     : 
Date & Time of Admission  : 
Date of Surgery    : 
Date & Time of Discharge  : 
Type of Surgery    :  
Chief Complaints    : 
       H/o fever 
       H/o redness along the suture line 
       H/o discharge from wound 
       H/o swelling along the suture line 
Basic Investigations   : 
     Complete Blood Count 
     Pus Culture & Sensitivity 
Findings      
Erythema & Redness +/_ 
     Induration 
     Fever +/_ 
     Stitch Abscess / Granuloma +/_ 
     Wound gaping +/_ 
     Wound discharge +/_ 
    Duration of hospital stay               : 
    Wound infection rate                     : 
  
 
 
ABBREVIATIONS  USED IN MASTER CHART 
 
SSI  -  SURGICAL SITE INFECTION 
RT  -  RIGHT 
LT  -  LEFT 
BL  -  BILATERAL 
LAP  -  LAPAROSCOPY 
SNG  -  SOLITARY NODULE GOITRE 
MNG  -  MULTINODULAR GOITRE 
CA  -  CARCNOMA 
MRM  -  MODIFIED RADICAL MASTECTOMY 
SUPL  -  SUPERFICIAL 
TEP  -  TOTAL EXTRA PERITONEAL REPAIR 
TAPP  -      TRANS ABDOMINAL PRE PERITONEAL REPAIR 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
MASTER CHART  FOR STUDY GROUP 
S. NAME AGE SEX IP 
NO. 
DIAGNOSIS  PROCEDURE DURATION 
OF 
SURGERY 
 SSI TYPE OF SSI ISOLATES 
FROM SSI 
DURATION 
OF POST-
OP STAY NO 
1 THAVAMANI 63 M 71952 LEFT DIRECT 
INGUINAL HERNIA 
L T. OPEN HERNIOPLASTY 1.2 NO - - 4 
2 SUBRAMANI 30 M 71971 RIGHT INDIRECT  
INGUINAL HERNIA 
RT. OPEN HERNIOPLASTY 1.3 NO - - 3 
3 HARIKRISHNAN 65 M 72004 LEFT INDIRECT  
INGUINAL HERNIA 
LT. OPEN HERNIOPLASTY 1.3 NO - - 4 
4 KRISHNAN 57 M 65469 RIGHT INDIRECT  
INGUINAL HERNIA 
RT. OPEN HERNIOPLASTY 1.1 NO - - 3 
5 HANIFFA 56 M 63857 LEFT DIRECT  
INGUINAL HERNIA 
LT. OPEN HERNIOPLASTY 1.3 NO - - 4 
6 BALAMURUGAN 22 M 78670 LEFT INDIRECT  
INGUINAL HERNIA 
LT. OPEN HERNIOPLASTY 1.2 NO - - 5 
7 ANANDHAN 45 M 78666 RIGHT DIRECT  
INGUINAL HERNIA 
RT. OPEN HERNIOPLASTY 1.2 NO - - 4 
8 SANKARAN 80 M 80276 RIGHT 
BUBONOCELE   
RT. OPEN HERNIOPLASTY 2  YES SUPL. 
INCISIONAL 
STAPH.AUREUS 8 
9 ALAGAR 26 M 80370 RIGHT CONGENITAL  
INGUINAL HERNIA 
RT. OPEN HERNIOPLASTY 1.2 NO - - 5 
10 MURUGESAN 58 M 27341 RIGHT DIRECT  
INGUINAL HERNIA 
RT. OPEN HERNIOPLASTY 1.3 NO - - 4 
11 KAMUSELVAM 19 M 61690 RIGHT INDIRECT  
INGUINAL HERNIA 
RT. OPEN HERNIOPLASTY 1.4 NO - - 5 
12 RADHAKRISHNAN 32 M 11625 RIGHT INDIRECT  
INGUINAL HERNIA 
RT. OPEN HERNIOPLASTY 1.1 NO - - 4 
13 THANGARAJ 67 M 11491 LEFT INDIRECT  
INGUINAL HERNIA 
LT. OPEN HERNIOPLASTY 1.2 NO - - 4 
  
14 MANOHARAN 49 M 14873 RIGHT INDIRECT  
INGUINAL HERNIA 
RT. OPEN HERNIOPLASTY 1.2 NO - - 5 
15 PALANIYANDI 60 M 16656 RIGHT INDIRECT  
INGUINAL HERNIA 
RT. OPEN HERNIOPLASTY 1.3 NO - - 5 
16 PANDI 60 M 16672 LEFT INDIRECT  
INGUINAL HERNIA 
LT. OPEN HERNIOPLASTY 1.2 NO - - 4 
17 PALPANDI 43 M 23880 RIGHT INDIRECT  
INGUINAL HERNIA 
RT. OPEN HERNIOPLASTY 1.1 NO - - 6 
18 RANJITH 20 M 24881 LEFT DIRECT  
INGUINAL HERNIA 
LT. OPEN HERNIOPLASTY 1.4 NO - - 5 
19 SEKAR 53 M 21701 RIGHT INDIRECT  
INGUINAL HERNIA 
RT. OPEN HERNIOPLASTY 1.3 NO - - 6 
20 ALAGHU 45 M 77052 BILATERAL  
INGUINAL HERNIA   
BL OPEN HERNIOPLASTY 1.3 NO - - 5 
21 SINGAKUTTI 60 M 80380 BILATERAL  
INGUINAL HERNIA 
BL OPEN HERNIOPLASTY 2.2 NO - - 5 
22 ARUNA 65 M 79604 BILATERAL  
INGUINAL HERNIA 
BL OPEN HERNIOPLASTY 2.1 YES DEEP 
INCISIONAL 
E.COLI 9 
23 KARUPPIAH 60 M 13296 BILATERAL  
INGUINAL HERNIA 
BL OPEN HERNIOPLASTY 2.3 NO - - 6 
24 JOSUA 47 M 81340 BILATERAL  
INGUINAL HERNIA 
LAP HERNIOPLASTY 2.5 NO - - 5 
25 SAGAYARAJ 27 M 11490 BILATERAL  
INGUINAL HERNIA 
LAP HERNIOPLASTY 2.7 NO - - 6 
26 ALAGARPANDI 40 M 43619 BILATERAL  
INGUINAL HERNIA 
LAP HERNIOPLASTY 2 NO   - 6 
27 SHOBA 37 F 68678 LEFT SNG THYROID LT.HEMITHYROIDECTOMY 1.3 NO - - 5 
28 DEVAKI 55 F 73817 LEFT SNG THYROID LT.HEMITHYROIDECTOMY 1.5 NO - - 5 
29 JANAKI 60 F 57279 COLLOID GOITRE TOTAL THYROIDECTOMY 1.7 NO - - 4 
30 SURULIAMMAL 60 F 77033 MNG TOTAL THYROIDECTOMY 2 NO - - 6 
31 UDAYA KUMAR 53 M 79814 MNG TOTAL THYROIDECTOMY 1.8 NO - - 6 
  
32 SELVI 28 F 10804 MNG TOTAL THYROIDECTOMY 1.7 NO - - 6 
33 ARULKUMAR 35 M 72249 LIPOMA NAPE OF 
NECK 
EXCISION 0.3 NO - - 1 
34 KANNAN 45 M 68472 LIPOMA NAPE OF 
NECK 
EXCISION 0.25 NO - - 1 
35 MANIKALAI 55 M 60722 LIPOMA NAPE OF 
NECK 
EXCISION 0.3 NO - - 1 
36 VEERANAM 57 M 79670 LIPOMA NAPE OF 
NECK 
EXCISION 0.2 NO - - 1 
37 INDIRANI 32 F 36275 LIPOMA NAPE OF 
NECK 
EXCISION 0.25 NO - - 1 
38 BALA 70 M 63672 LIPOMA NAPE OF 
NECK 
EXCISION 0.25 NO - - 1 
39 SHANMUGAVALLI 40 F 12786 CA LEFT BREAST LEFT MRM 2.3 NO - - 6 
40 MURUGESWARI 35 F 14899 CA LEFT BREAST LEFT MRM 2.4 NO - -- 5 
41 DANALAKSHMI 64 F 14988 CA  RIGHT BREAST RIGH MRM 1.8 NO - - 6 
42 PREMA 39 F 23133 CA LEFT BREAST LEFT MRM 1.4 NO - - 6 
43 SIVAGAMI 15 F 64790 FIBROADENOMA 
LEFT BREAST 
EXCISION 1.3 NO - - 2 
44 MUNEESWARI 20 F 36163 FIBROADENOMA 
RIGHT BREAST 
EXCISION 1.2 NO - - 3 
45 TAMILSELVI 22 F 36158 FIBROADENOMA 
LEFT BREAST 
EXCISION 1.2 NO   - 3 
46 RAJENDRAN 55 M 68415 BILATERAL 
HYDROCELE 
EVERSION OF SAC 0.8 NO - - 2 
47 KARUPPAN 60 M 68764 BILATERAL 
HYDROCELE 
EVERSION OF SAC 1 YES SUPL.INCISIONAL STAPH. 
AUREUS 
8 
48 AYYAKANNU 71 M 18652 BILATERAL 
HYDROCELE 
EVERSION OF SAC 0.9 NO - - 3 
49 MUTHU 17 M 78810 RIGHT HYDROCELE EVERSION OF SAC 1 NO - - 4 
50 ARIVALAZHAGAN 36 M 74759 LEFT  EPIDIDYMAL 
CYST 
EXCISION 0.5 NO - - 2 
  
MASTER CHART  FOR CONTROL GROUP 
S. 
NO. 
NAME AGE SEX IP 
NO. 
DIAGNOSIS PROCEDURE DURATION 
OF 
SURGERY 
SSI TYPE OF SSI ISOLATES OF SSI DURATION 
OF POST-OP 
STAY (DAYS) 
1 AYYAN 58 M 26619 RIGHT INDIRECT HERNIA OPEN HERNIOPLASTY-RT 1.2 NO - - 4 
2 SARAVANAN 36 M 30260 RIGHT INDIRECT  HERNIA OPEN HERNIOPLASTY-RT 1.4 NO - - 4 
3 PARAMASIVAM 55 M 24843 LEFT DIRECT  HERNIA OPEN HERNIOPLASTY-LT 1.3 NO - - 5 
4 JOTHIMANI 13 M 32197 LEFT CONGENITAL  HERNIA OPEN HERNIOPLASTY-LT 1.3 NO - - 3 
5 SUBRAMANI 44 M 36141 RIGHT INDIRECT  HERNIA OPEN HERNIOPLASTY-RT 1.7 NO - - 5 
6 SUNDARAPANDI 20 M 36104 RIGHT INDIRECT  HERNIA OPEN HERNIOPLASTY-RT 1.5 NO - - 3 
7 MUTHURAKKU 57 M 36105 LEFT DIRECT  HERNIA OPEN HERNIOPLASTY-LT 1.5 NO - - 5 
8 DURAIPANDI 54 M 36116 RIGHT INDIRECT  HERNIA OPEN HERNIOPLASTY-RT 1.6 NO - - 6 
9 KANDASAMY 65 M 42059 RIGHT DIRECT  HERNIA OPEN HERNIOPLASTY-RT 1.6 YES SUPL. 
INCISIONAL 
STAPH AUREUS 8 
10 MOHAMED YUSUF 24 M 41771 LEFT INDIRECT  HERNIA OPEN HERNIOPLASTY-LT 1.6 NO - - 3 
11 SONAIMUTHU 38 M 43622 RIGHT INDIRECT  HERNIA OPEN HERNIOPLASTY-RT 1.4 NO - - 4 
12 KARUPPUSAMY 53 M 48094 LEFT DIRECT  HERNIA OPEN HERNIOPLASTY-LT 1.8 NO - - 5 
13 KALAIPANDI 55 M 51789 LEFT DIRECT  HERNIA OPEN HERNIOPLASTY-LT 1.7 YES SUPL. 
INCISIONAL 
STAPH AUREUS 9 
14 ADHIMOOLAM 48 M 49832 LEFT DIRECT  HERNIA OPEN HERNIOPLASTY-LT 1.8 NO - - 4 
15 ROOBANRAJ 29 M 63680 LEFT INDIRECT  HERNIA OPEN HERNIOPLASTY-LT 1.7 NO - - 6 
16 AMIRTHALINGAM 24 M 63770 LEFT INDIRECT  HERNIA OPEN HERNIOPLASTY-LT 1.7 NO - - 7 
17 BALAMURUGAN 42 M 21775 BILATERAL  HERNIA OPEN HERNIOPLASTY-`BL 1.6 NO - - 8 
18 AZHAGAN 50 M 26690 BIL ATERAL HERNIA OPEN HERNIOPLASTY-BL 2.1 NO - - 7 
19 HASSAN 57 M 32164 BILATERAL  HERNIA OPEN HERNIOPLASTY-BL 2.4 YES DEEP 
INCISIONAL 
E.COLI 11 
  
20 CHANDRASEKHAR 38 M 34243 BILATERAL  HERNIA OPEN HERNIOPLASTY-BL 2.1 NO - - 6 
21 LAXMAN 45 M 38003 BILATERAL  HERNIA OPEN HERNIOPLASTY-BL 2.3 NO - - 4 
22 SETHUPANDI 46 M 47463 BILATERAL HERNIA TEP 2.5 NO - - 3 
23 VELSAMY 55 M 11462 LEFT DIRECT INGUINAL 
HERNIA 
TEP 2.6 NO - - 3 
24 ISRAEL 50 M 26663 LEFT DIRECT INGUINAL 
HERNIA 
TEP 2.3 NO - - 2 
25 SUBRAMANI 40 M 32750 RIGHT BUBONOCELE TEP 2.4 NO - - 3 
26 RAJESWARI 54 F 11587 MNG TOTAL THYROIDECTOMY 1.8 NO - - 3 
27 KANNAMMAL 50 F 28514 MNG TOTAL THYROIDECTOMY 1.7 NO - - 4 
28 PALANIAMMAL 32 F 30275 MNG TOTAL THYROIDECTOMY 2 NO - - 3 
29 POORNAM 25 F 38013 MNG TOTAL THYROIDECTOMY 1.9 NO - - 3 
30 PALANIAMMAL 53 F 38042 MNG TOTAL THYROIDECTOMY 2.1 NO - - 5 
31 PECHIAMMAL 25 F 68862 LEFT SNG LEFT 
HEMITHYROIDECTOMY 
1.2 NO - - 2 
32 DHANALAKSHMII 33 F 13271 RIGHT SNG RIGHT  
HEMITHYROIDECTOMY 
1.4 NO - - 2 
33 MANI 58 M 36427 LIPOMA NAPE OF NECK EXCISION 0.33 NO - - 1 
34 MURUGESAN 36 M 13234 LIPOMA BACK EXCISION 0.5 NO - - 1 
35 MARIMUTHU 40 M 16478 LIPOMA NAPE OF NECK EXCISION 0.5 NO - - 1 
36 LAKSHMIPRIYA 19 F 67185 LIPOMA BACK EXCISION 0.4 NO - - 1 
37 NAGAVALLI 35 F 23033 CA  RIGHT BREAST RIGHT MRM 1.8 NO - - 7 
38 RASATHI 47 F 19870 CA  RIGHT BREAST RIGHT MRM 1.7 YES SUPFL. 
INCISIONAL 
KLEBSIELLA 11 
39 PANDIMEENA 46 F 50964 CA  LEFT BREAST LEFT MRM 1.8 YES DEEP 
INCISIONAL 
PSEUDOMONAS 13 
40 TAMILSELVI 32 F 53197 CA  RIGHT BREAST RIGHT MRM 1.5 NO - - 8 
41 SELVAM 33 F 57694 CA  RIGHT BREAST RIGHT MRM 2 NO - - 6 
42 VASANTHI 24 F 36143 FIBROADENOMA RT BREAST EXCISION 0.7 NO - - 2 
  
43 CHINNAMALAR 15 F 43523 GIANT FIBROADENOMA LT 
BREAST 
EXCISION 0.5 NO -   3 
44 SELVAM 43 F 45401 LUMP LEFT BREAST EXCISION 0.6 NO - - 2 
45 MADASAMY 54 M 61720 RIGHT HYDROCELE EVERSION OF SAC 0.4 NO - - 4 
46 AMEER 70 M 26751 RIGHT HYDROCELE EVERSION OF SAC 0.5 YES SUPFL. 
INCISIONAL 
STAPH AUREUS 9 
47 RADHAKRISHNAN 65 M 15683 LEFT  HYDROCELE EVERSION OF SAC 0.6 NO - - 3 
48 LAKSHMANAN 35 M 63848 LEFT  HYDROCELE EVERSION OF SAC 0.7 NO - - 4 
49 RAMAR 52 M 71158 LEFT  HYDROCELE EVERSION OF SAC 0.6 NO - - 3 
50 SOKKALINGAM 55 M 11496 RIGHT  EPIDIDYMAL CYST EXCISION 0.5 NO - - 3 
 
 
 
 
 
 
 
 
 
  
 
 
 
  
 
 
 
 
 
 
  
 
